David Gani

4.2k total citations · 1 hit paper
128 papers, 3.3k citations indexed

About

David Gani is a scholar working on Molecular Biology, Biochemistry and Organic Chemistry. According to data from OpenAlex, David Gani has authored 128 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 30 papers in Biochemistry and 29 papers in Organic Chemistry. Recurrent topics in David Gani's work include Amino Acid Enzymes and Metabolism (30 papers), Enzyme Structure and Function (23 papers) and Chemical Synthesis and Analysis (22 papers). David Gani is often cited by papers focused on Amino Acid Enzymes and Metabolism (30 papers), Enzyme Structure and Function (23 papers) and Chemical Synthesis and Analysis (22 papers). David Gani collaborates with scholars based in United Kingdom, United States and Switzerland. David Gani's co-authors include Martin D. Ryan, Lorraine E. Hughes, Michelle Donnelly, Garry A. Luke, Amit P. Mehrotra, Xue-Jun Li, Claire Halpin, Pablo de Felipe, Garry A. Luke and Janis K. Shute and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

David Gani

128 papers receiving 3.1k citations

Hit Papers

Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ ... 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gani United Kingdom 24 2.1k 543 423 359 333 128 3.3k
Masao Kawakita Japan 38 3.3k 1.6× 266 0.5× 228 0.5× 508 1.4× 301 0.9× 138 4.1k
Akira Takatsuki Japan 38 4.1k 1.9× 1.0k 1.9× 659 1.6× 452 1.3× 199 0.6× 151 6.6k
Urszula Derewenda United States 42 4.9k 2.3× 463 0.9× 239 0.6× 374 1.0× 356 1.1× 81 6.5k
Gary E. Means United States 23 2.1k 1.0× 393 0.7× 217 0.5× 321 0.9× 158 0.5× 55 3.5k
Mario A. Bianchet United States 36 2.6k 1.2× 459 0.8× 208 0.5× 226 0.6× 79 0.2× 78 3.8k
André Trouet Belgium 30 2.2k 1.0× 357 0.7× 138 0.3× 191 0.5× 169 0.5× 96 4.4k
Frank Rusnak United States 38 3.3k 1.6× 262 0.5× 392 0.9× 245 0.7× 94 0.3× 81 4.9k
F. Eckstein Germany 46 5.4k 2.5× 839 1.5× 195 0.5× 408 1.1× 194 0.6× 141 6.5k
Alexander B. Taylor United States 35 2.4k 1.2× 586 1.1× 308 0.7× 158 0.4× 123 0.4× 87 4.6k
Hiroshi Ueda Japan 37 3.7k 1.8× 342 0.6× 156 0.4× 325 0.9× 69 0.2× 296 5.5k

Countries citing papers authored by David Gani

Since Specialization
Citations

This map shows the geographic impact of David Gani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gani more than expected).

Fields of papers citing papers by David Gani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gani. The network helps show where David Gani may publish in the future.

Co-authorship network of co-authors of David Gani

This figure shows the co-authorship network connecting the top 25 collaborators of David Gani. A scholar is included among the top collaborators of David Gani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gani. David Gani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, David J., et al.. (2004). Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity. Organic & Biomolecular Chemistry. 2(5). 671–671. 12 indexed citations
2.
Biggadike, Keith, et al.. (2003). Structure–activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(10). 1623–1626. 18 indexed citations
3.
Asunción, Miryam, Wulf Blankenfeldt, John N. Barlow, David Gani, & James H. Naismith. (2002). The Structure of 3-Methylaspartase from Clostridium tetanomorphum Functions via the Common Enolase Chemical Step. Journal of Biological Chemistry. 277(10). 8306–8311. 27 indexed citations
4.
Asunción, Miryam, John N. Barlow, John R. Pollard, et al.. (2001). Overexpression, purification, crystallization and data collection of 3-methylaspartase fromClostridium tetanomorphum. Acta Crystallographica Section D Biological Crystallography. 57(5). 731–733. 2 indexed citations
5.
Rutherford, Trevor J., et al.. (2001). NMR STUDIES AND SEMI-EMPIRICAL ENERGY CALCULATIONS FOR CYCLIC ADP-RIBOSE. Nucleosides Nucleotides & Nucleic Acids. 20(8). 1485–1495. 2 indexed citations
6.
8.
Donnelly, Michelle, Martin D. Ryan, Mike Flint, David Gani, & Sean J. Monaghan. (1997). The cleavage activities of aphthovirus and cardiovirus 2A proteins.. Journal of General Virology. 78(1). 13–21. 143 indexed citations
10.
Camp, Nicholas P., David A. Perrey, Derek Kinchington, Paul C. D. Hawkins, & David Gani. (1995). Synthesis of peptide analogues containing phosphonamidate methyl ester functionality: HIV-1 proteinase inhibitors possessing unique cell uptake properties. Bioorganic & Medicinal Chemistry. 3(3). 297–312. 14 indexed citations
11.
Gani, David, C. Peter Downes, Ian H. Batty, & Janice Bramham. (1993). Lithium and myo-inositol homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1177(3). 253–269. 57 indexed citations
12.
Botting, Nigel P. & David Gani. (1992). Mechanism of C-3 hydrogen exchange and the elimination of ammonia in the 3-methylaspartate ammonia-lyase reaction. Biochemistry. 31(5). 1509–1520. 15 indexed citations
13.
Goda, Sayed K., Nigel P. Minton, Nigel P. Botting, & David Gani. (1992). Cloning, sequencing, and expression in Escherichia coli of the Clostridium tetanomorphum gene encoding .beta.-methylaspartase and characterization of the recombinant protein. Biochemistry. 31(44). 10747–10756. 38 indexed citations
14.
Gani, David. (1991). A structural and mechanistic comparison of pyridoxal 5'-phosphate dependent decarboxylase and transminase enzymes. Philosophical Transactions of the Royal Society B Biological Sciences. 332(1263). 131–139. 9 indexed citations
15.
Smith, Douglas M., Neil R. Thomas, & David Gani. (1991). A comparison of pyridoxal 5′-phosphate dependent decarboxylase and transaminase enzymes at a molecular level. Cellular and Molecular Life Sciences. 47(11-12). 1104–1118. 17 indexed citations
16.
Gani, David, et al.. (1991). Inositol dependent phosphate-oxygen ligand exchange catalysed by inositol monophosphatase.. Bioorganic & Medicinal Chemistry Letters. 1(4). 193–196. 19 indexed citations
18.
Stevenson, D. E., et al.. (1990). Fern L-methionine decarboxylase: kinetics and mechanism of decarboxylation and abortive transamination. Biochemistry. 29(33). 7648–7660. 22 indexed citations
19.
Gani, David, P.J. Hendra, W. F. Maddams, et al.. (1990). Fourier transform Raman spectroscopy in the analysis of polypeptides. The Analyst. 115(10). 1313–1313. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026